Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive brain stimulation technologies ...

The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under physician oversight.

$11 million in proceeds expected to be received during 2026, with remainder of expected proceeds to be received in future revenue earnouts Vivasure Medical Limited (“Vivasure”) has been a strategic ...

With Moleculin’s WP1066 oral formulation, an externally funded Phase 2 trial in combination with radiation treating GBM, a form of brain cancer, is recruiting and treating subjects at Northwestern ...

Focused on therapies for endocrine and oncologic conditions, this biotech reported significant insider selling in its latest ...

Abstract: Currently, two main research lines in efficient context modeling for image dehazing are tailoring effective feature modulation mechanisms and utilizing the Fourier transform more precisely.

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

LumiMind, a next-generation neurotechnology company focused on restoring the brain's natural rhythm, today announced the launch of LumiSleep at CES 2026 in Las Vegas. LumiSleep is the first-ever ...

Newron's partner EA Pharma Co., Ltd. announces today the initiation of its Phase III clinical trial with evenamide in Japan.

In visual cortex, neural correlates of subjective perception can be generated by modulation of activity from beyond the classical receptive field (CRF). In macaque V1, activity generated by ...

Data published in Scientific Reports confirms a low-burden visual evoked potential (VEP) assessment can be employed across multiple clinical trial sites as an objective measure of neuroplastic ...